ISIS Voice Present at the AMA House of Delegates Meeting

Claire Tibiletti, MD and Andrew Yu, MD represented ISIS at the AMA House of Delegates Annual Meeting June 15-19, 2013. Some of the key policies that were passed at the meeting were:

· Scope of Practice
Comprehensive guidelines on the definition of invasive pain management procedures for the treatment of chronic pain – this was an addition to previously passed policy, which stated that the AMA should actively advocate that interventional chronic pain management is within the practice of medicine and should be performed only by physicians.

· Compounding Pharmacies

Comprehensive policy on compounding pharmacies, including a provision that the AMA supports the view that facilities (other than pharmacies within a health system) that compound sterile drug products without receiving a prescription prior to beginning compounding to be recognized as compounding manufacturers subject to FDA oversight and regulation.

· ­Drug Shortages

In addition to current policies and a comprehensive report on drug shortages which is developed annually, the AMA HOD voted on a provision to advocate for government stockpiling of oral and intravenous parenteral drug shortage products, or for removal of government policy price controls to mitigate against an unfair manufacturing free marketplace. The AMA will also develop a webpage resource dedicated to drug shortages and continue to evaluate the drug shortage issue.